Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Syros Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +11 vs. Q3 2023
- Shares held
- 19.2M
- +8.41M (+77.6%) vs. Q3 2023
- Total value
- $146.8M
- +$104.0M (+242.9%) vs. Q3 2023
- New holders
- 16
- 16 more added
- Sold out
- 5
- 8 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SYRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $12.4K |
| Q4 2024 | 44 | $1.20M |
| Q3 2024 | 65 | $40.8M |
| Q2 2024 | 70 | $105.2M |
| Q1 2024 | 75 | $111.9M |
| Q4 2023 | 58 | $146.8M |
| Q3 2023 | 48 | $47.9M |
| Q2 2023 | 53 | $33.5M |
| Q1 2023 | 59 | $27.5M |
| Q4 2022 | 57 | $37.9M |
| Q3 2022 | 53 | $59.9M |
| Q2 2022 | 69 | $34.2M |
| Q1 2022 | 94 | $53.1M |
| Q4 2021 | 90 | $166.0M |
| Q3 2021 | 100 | $223.1M |
| Q2 2021 | 100 | $276.0M |
| Q1 2021 | 106 | $475.8M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Syros Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | 8 | $62 | 0.00% | +8 | New |
| PSI Advisors, LLC | 13 | $101 | 0.00% | +13 | New |
| Sound Income Strategies, LLC | 76 | $592 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 129 | $1.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 438 | $3.41K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 540 | $4.20K | 0.00% | −101−15.8% | Reduced |
| JPMorgan Chase & Co | 549 | $4.28K | 0.00% | −528−49.0% | Reduced |
| Rhumbline Advisers | 659 | $5.13K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 750 | $5.84K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,083 | $8.44K | 0.00% | +787+265.9% | Added |
| The PNC Financial Services Group, Inc. | 1,095 | $8.53K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,279 | $9.96K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,619 | $12.6K | 0.00% | −3,079−65.5% | Reduced |
| Royal Bank of Canada | 3,000 | $23.0K | 0.00% | +2,058+218.5% | Added |
| Edmond de Rothschild Holding S.A. | 4,382 | $34.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 6,180 | $48.1K | 0.00% | +6,180 | New |
| Integrated Wealth Concepts LLC | 10,000 | $77.9K | 0.00% | +10,000 | New |
| Bank of America Corp | 10,021 | $78.1K | 0.00% | +9,953+14,636.8% | Added |
| Y-Intercept (Hong Kong) Ltd | 10,512 | $81.9K | 0.01% | +10,512 | New |
| XTX Topco Ltd | 11,006 | $85.7K | 0.02% | +11,006 | New |
| CI Private Wealth, LLC | 12,000 | $93.5K | 0.00% | −14,666−55.0% | Reduced |
| HighTower Advisors, LLC | 15,004 | $117.0K | 0.00% | 00.0% | Unchanged |
| CIBC Asset Management Inc | 15,398 | $120.0K | 0.00% | 00.0% | Unchanged |
| Clarius Group, LLC | 18,620 | $145.1K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 21,135 | $164.6K | 0.00% | +21,135 | New |
| 1492 Capital Management LLC | 21,744 | $169.4K | 0.10% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 22,550 | $176.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 24,818 | $193.3K | 0.00% | +24,818 | New |
| Assenagon Asset Management S.A. | 25,130 | $195.8K | 0.00% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 36,444 | $283.9K | 0.03% | +36,444 | New |
| Bridgeway Capital Management, LLC | 39,500 | $307.7K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 39,970 | $311.4K | 0.00% | +13,576+51.4% | Added |
| State Street Corp | 49,430 | $385.1K | 0.00% | +16,300+49.2% | Added |
| Two Sigma Investments, LP | 54,654 | $425.8K | 0.00% | +54,654 | New |
| LGT Capital Partners Ltd. | 55,000 | $428.4K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 58,635 | $457.0K | 0.00% | +9,400+19.1% | Added |
| Knott David M Jr | 79,927 | $623.0K | 0.24% | −26,048−24.6% | Reduced |
| LPL Financial LLC | 81,525 | $635.1K | 0.00% | −8,650−9.6% | Reduced |
| EAM Investors, LLC | 84,002 | $654.4K | 0.12% | +84,002 | New |
| Tang Capital Management LLC | 85,031 | $662.4K | 0.06% | +85,031 | New |
| ExodusPoint Capital Management, LP | 103,522 | $806.0K | 0.01% | −4,615−4.3% | Reduced |
| UBS Oconnor LLC | 130,000 | $1.01M | 0.03% | +130,000 | New |
| Geode Capital Management, LLC | 161,563 | $1.26M | 0.00% | +23,698+17.2% | Added |
| DAFNA Capital Management LLC | 214,885 | $1.67M | 0.40% | −50,993−19.2% | Reduced |
| Goldman Sachs Group Inc | 239,681 | $1.87M | 0.00% | +133,149+125.0% | Added |
| BlackRock Inc. | 246,944 | $1.92M | 0.00% | +1,199+0.5% | Added |
| Omega Fund Management, LLC | 251,270 | $1.96M | 1.59% | 00.0% | Unchanged |
| Opaleye Management Inc. | 359,370 | $2.80M | 0.75% | +359,370 | New |
| Vanguard Group Inc | 764,812 | $5.96M | 0.00% | +236,620+44.8% | Added |
| Deep Track Capital, LP | 828,485 | $6.45M | 0.23% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 1,493,252 | $8.46M | 2.02% | +1,493,252 | New |
| Flagship Pioneering Inc. | 1,293,848 | $10.1M | 0.76% | +300,000+30.2% | Added |
| Point72 Asset Management, L.P. | 1,471,771 | $11.5M | 0.03% | +1,471,771 | New |
| Avidity Partners Management LP | 1,673,538 | $13.0M | 0.50% | +92,396+5.8% | Added |
| Samsara BioCapital, LLC | 1,786,427 | $13.9M | 2.16% | +904,977+102.7% | Added |
| Adage Capital Partners GP, L.L.C. | 2,071,914 | $16.1M | 0.03% | +1,350,000+187.0% | Added |
| Artal Group S.A. | 2,505,013 | $19.5M | 0.67% | +1,029,269+69.7% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,749,808 | $21.4M | 2.05% | +625,114+29.4% | Added |
| Shay Capital LLC | 0 | $0 | 0.00% | −23,776−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,093−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −346−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| CHI Advisors LLC | – | – | – | – | Not filed |